Find a TB006 Provider Near You

Start your journey toward understanding your TB006 options—now available through specialized providers nationwide.

Find a Provider

Featured Medical Providers

About TB006

TBOO6: A New Era in Alzheimer’s Therapy

Unlike some existing medications that focus on symptom management, TB006 targets Galectin-3, a protein associated with inflammation in the brain — though its effects may vary by patient.

TB006 may support brain health by:

  • May help reduce certain markers of brain inflammation associated with Alzheimer’s disease, in some patients
  • May support neurological function in some patients, though individual results vary

Some patients in the Expanded Access Program have reported improvements in cognitive symptoms. Individual results vary and are not guaranteed.

If you or someone you love has been diagnosed with mild to moderate Alzheimer’s, you may be eligible for TB006 treatment through a participating doctor.

Resources

Insights That Advance Brain Health

Testimonials

Real Stories of Minds Reclaimed and Lives Restored

The following are individual patient experiences reported under the FDA’s Expanded Access Program. TB006 is an investigational drug and has not been approved by the FDA. These results are not typical and may not reflect your experience. Individual outcomes vary.

Find a TB006 Provider Near You

Where Are You Located?

Please select your city so we can show nearby providers.